Zenith's tolazamide
Executive Summary
Shipments of the Tolinase generic began Oct. 3 following final FDA approval. Firm said its prices are 50% of Upjohn's direct price to drug stores as listed in the July Redbook. Upjohn figures were $53.51 for 250 mg 200s and $261.25 for 250 mg 1,000s. Zenith said initial shipments of its 100, 250 and 500 mg tolazamide are in excess of $1 mil. A generic version of Pfizer's Diabinese (chlorpropamide) will also be introduced after the patent expires Oct. 24
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.